World's #1 cosmetics, L'Oréal (~€220B market cap) owns 36 brands including L'Oréal Paris, Lancôme, Maybelline, Garnier, La Roche-Posay, Kiehl's. Regular growth and defensive resilience.
CAC 40 index — L'Oréal (OR.PA) is its #2 component (~9 % weight). For live L'Oréal price, see Boursorama, Yahoo Finance or your broker.
L'Oréal is the world's #1 cosmetics for 70 years, ahead of Estée Lauder, Procter & Gamble (Olay, Pantene), Unilever (Dove, Vaseline) and Shiseido. 2024 revenue: ~€42B (+5.6 % LFL), net profit: ~€6.6B. Market cap: ~€220B (CAC 40 #2 behind LVMH).
4 strategic divisions:
1. Professional Products (10 % of revenue): Kérastase, Redken, L'Oréal Professionnel — distributed in hair salons and beauty institutes. 22-25 % margins.
2. Consumer Products (40 %): L'Oréal Paris, Maybelline, Garnier, NYX — sold in mass retail. Massification, lower margins 18-20 %.
3. L'Oréal Luxe (40 %): Lancôme, Yves Saint Laurent Beauté, Helena Rubinstein, Giorgio Armani Beauty, Ralph Lauren, Prada Beauty, Kiehl's, Urban Decay. 22-25 % margins, strongest growth (+8 %/year).
4. Active Cosmetics / Dermo-cosmetics (10 %, strong growth): La Roche-Posay, Vichy, CeraVe (acquired 2017 for $1.3B, became #1 dermato US), SkinCeuticals. 25 % margins, +15 %/year growth.
Geographic presence: - Europe: ~30 % of revenue - North America: ~30 % (CeraVe exploding here) - China + North Asia: ~25 % (vs 35 % before 2023, slowdown) - Emerging markets (India, Brazil, Mexico): ~15 %, +15-20 %/year growth
Bettencourt family: Françoise Bettencourt-Meyers (granddaughter of founder Eugène Schueller) holds ~33 % via Téthys holding. She's France's #1 fortune (~$70B per Forbes 2025). Strong shareholder power, progressive transmission to sons Jean-Victor and Nicolas Bettencourt-Meyers.
CEO: Nicolas Hieronimus (since 2021), French polytechnician, rises internally (25 years at L'Oréal). Strategy: "premiumisation" + dermo-cosmetics + digital.
2023-2024: complicated period for L'Oréal in China, where group lost momentum. 2024-2026: rebound thanks to US and emerging markets.
The Chinese problem (2023-2024): - L'Oréal Luxe China -10 % in 2024 (vs +30 % in 2021) - Real estate crisis + anti-luxury policy + rise of local brands (Shanghai Pechoin, Proya, Florasis) - Daigou crackdown: less tourist shopping in France/Korea for resale in China - Hieronimus admitted: "We bet too much on China, must rebalance"
The American rebound (2024-2026): - CeraVe: the gem. Acquired $1.3B in 2017, worth ~$15-20B today. +30 %/year growth, dermato leader with US dermatologists. - TikTok beauty: L'Oréal dominated social commerce revolution (Maybelline, NYX, Lancôme x Beyoncé). Gen Z buys on TikTok Shop. - Walmart, Target, Sephora US: solid physical sales (+8 %)
Emerging markets in great shape: - India: +20 %/year, future locomotive (1.4B population) - Brazil: Niely (acquired 2014) local leader - Mexico, Poland, Turkey: strong growth
Stock price evolution: - Peak at €460 in May 2023 (€245B market cap) - Drop to €350 in September 2024 (-24 %, China fear) - Rebound to €410 in April 2026 (~€220B)
2026-2027 catalysts: 1. China stabilization: if China returns +5 %, Lancôme can recover +30 % 2. CeraVe globalization: extending CeraVe to Europe and Asia (still little present) 3. Targeted acquisitions: L'Oréal has €5-7B cash available to acquire (Aēsop? another dermato?) 4. Bettencourt family: progressive transmission without strategy change = capital stability
Current ratios (April 2026): - Price: ~€410 - Forward 2026 PE: 27 (premium vs CAC 40 avg 17, but justified by +6-8 %/year growth) - Dividend: €7/share (1.7 % yield) - Market cap: ~€220B
Bull case (buy): 1. Constant organic growth: +5-8 %/year for 30 years, never negative revenue year (except Covid) 2. Pricing power: can raise prices 5-7 %/year without volume loss (beauty = inelastic) 3. Geographic diversification: USA + Europe + Emerging offset Chinese slowdown 4. Dermo-cosmetics booming: CeraVe and La Roche-Posay surf "skinification" of care 5. Exceptional balance sheet: zero net debt, €5-7B cash, near AAA 6. Bettencourt family stable shareholder: no hostile raid risk or strategic shift
Bear case (avoid): 1. Premium valuation: 27 PE vs CAC avg 17 — already paid a lot 2. Prolonged China risk: if Chinese slowdown lasts 2-3 more years 3. Beauty disruptor competition: challenger brands in Asia + American DTC (Glossier, Rare Beauty, Fenty) 4. Cosmetics regulation: ingredient restrictions in Europe (PFAS, perfluorinated) raise R&D costs 5. Inflation effect: mass market can switch to low-cost brands in recession
How to invest L'Oréal:
1. Direct stock on Euronext Paris - Code: OR (Euronext) - 1 share = ~€410 - PEA-eligible: yes, tax exemption after 5 years - Dividend: paid in May (1 time/year), typical late-April ex-date
2. Luxury / consumer ETF - Amundi S&P Global Luxury (LUXR): L'Oréal ~5 %, LVMH, Hermès - Lyxor MSCI Europe Quality (UEQ): L'Oréal present as "quality" stock
3. World / Europe ETF - MEUD or Amundi MSCI World: L'Oréal ~1 %
Comparison with peers: - L'Oréal vs Estée Lauder (EL): L'Oréal better diversified, EL more exposed to US and China. EL fell 70 % since 2022, L'Oréal only -10 %. L'Oréal better managed. - L'Oréal vs Beiersdorf (Nivea, Eucerin): L'Oréal more high-end, Beiersdorf more defensive and cheaper (22 PE). - L'Oréal vs Procter & Gamble: P&G more diversified (diapers, detergent...), not pure beauty. To bet on pure beauty, L'Oréal.
Buying strategy: - DCA (Dollar Cost Averaging): monthly purchase over 12-18 months to smooth entry price - Buy on dip: if OR < €380, opportunistic buy - Long-term: 10-15 years to benefit from compound growth
My reco: PEA buy for long-term. L'Oréal is one of Europe's finest "compounders" (regular growth + growing dividend + solid balance sheet). Position 5-10 % of French portfolio. Stop loss at -25 % (~€310). No pause, just accumulation.
TotalEnergies shares are down after the company reported second-quarter results that were weaker than those of its British competitors. The European oil sector is showing mixed performance.
The U.S. president says the ceasefire with Iran is on life support. European stock markets are expected to open sharply lower on Tuesday.
CAC 40 futures are down 60 points to 8,110 points this Friday morning. The U.S. jobs report and tensions surrounding the Iran-U.S. ceasefire are weighing on the market at the open.
The French luxury giant's share price plummets after disappointing Q1 sales. War and currency effects cost the group 290 million euros.
The CAC 40 gained ground on Tuesday morning on the back of easing geopolitical tensions. But LVMH disappointed with sales down 6%.
The week kicks off with analysts' opinions on several CAC 40 stocks. Kering, Legrand and Sodexo are at the heart of this week's recommendation adjustments.
Paris, London and Frankfurt fell back at the start of the session. The failure of negotiations between Washington and Teheran has triggered a wave of risk aversion on the Old Continent.
European markets tumbled on Monday morning. Paris lost 0.94%, Frankfurt 0.96%, London 0.56%. Cause: tensions between Iran and the United States over a threatened port blockade.
The Q1 2026 results season begins on Monday with LVMH. Ten companies will publish on April 23. Get ready to follow the real performance of the French market.
An agreement between Iran and the United States boosts the French economy. OFCE forecasts growth of 0.8% in 2026 if energy prices return to normal.
European stock markets are back on the rise following the signing of a 15-day ceasefire between the United States and Iran, agreed just before Trump's ultimatum.
the year's sector rotation is underway